T Naftali

Summary

Affiliation: Tel Aviv University
Country: Israel

Publications

  1. doi request reprint Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study
    Timna Naftali
    Department of Gastroenterology and Hepatology, Meir Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Kfar Saba, Israel Electronic address
    Clin Gastroenterol Hepatol 11:1276-1280.e1. 2013
  2. ncbi request reprint Treatment of Crohn's disease with cannabis: an observational study
    Timna Naftali
    Institute of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba affiliated with Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
    Isr Med Assoc J 13:455-8. 2011
  3. doi request reprint Nonspecific esophageal motility disorders may be an early stage of a specific disorder, particularly achalasia
    T Naftali
    Department of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba, Israel
    Dis Esophagus 22:611-5. 2009
  4. doi request reprint Ziziphus jujuba extract for the treatment of chronic idiopathic constipation: a controlled clinical trial
    Timna Naftali
    Department of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba, Israel
    Digestion 78:224-8. 2008
  5. ncbi request reprint Post-infectious gastroparesis: clinical and electerogastrographic aspects
    Timna Naftali
    Motility Clinic, Gastroenterology Division, Meir Hospital, Kefar Saba, Israel
    J Gastroenterol Hepatol 22:1423-8. 2007
  6. ncbi request reprint Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation
    Timna Naftali
    Institute of Gastroenterology and Liver Diseases, Meir Hospital, Kfar Saba, Israel
    Isr Med Assoc J 9:504-8. 2007
  7. ncbi request reprint [Intra gastric balloon for morbid obesity]
    Naftali Timna
    Sapir Medical Center, Meir Hospital, Kefar Saba
    Harefuah 145:826-30, 861. 2006
  8. ncbi request reprint Cyclosporin for severe ulcerative colitis
    T Naftali
    Department of Gastroenterology, Meir Hospital, Kfar Saba
    Isr Med Assoc J 2:588-91. 2000
  9. pmc High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance
    R Towers
    Institute of Gastroenterology and Liver Diseases, Meir Hospital, Kfar Saba 4428, Israel
    Clin Exp Immunol 141:357-62. 2005
  10. pmc Helicobacter pylori: the Middle East scenario
    B H Novis
    Gastroenterology Unit, Meir Hospital, Kfar Saba, Israel
    Yale J Biol Med 71:135-41. 1998

Collaborators

Detail Information

Publications10

  1. doi request reprint Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study
    Timna Naftali
    Department of Gastroenterology and Hepatology, Meir Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Kfar Saba, Israel Electronic address
    Clin Gastroenterol Hepatol 11:1276-1280.e1. 2013
    ..We performed a prospective trial to determine whether cannabis can induce remission in patients with Crohn's disease...
  2. ncbi request reprint Treatment of Crohn's disease with cannabis: an observational study
    Timna Naftali
    Institute of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba affiliated with Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
    Isr Med Assoc J 13:455-8. 2011
    ..The marijuana plant cannabis is known to have therapeutic effects, including improvement of inflammatory processes. However, no report of patients using cannabis for Crohn's disease (CD) was ever published...
  3. doi request reprint Nonspecific esophageal motility disorders may be an early stage of a specific disorder, particularly achalasia
    T Naftali
    Department of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba, Israel
    Dis Esophagus 22:611-5. 2009
    ..NEMD is generally a benign disorder that improves clinically in most cases. Nevertheless, in about 6% of patients, NEMD may evolve into achalasia...
  4. doi request reprint Ziziphus jujuba extract for the treatment of chronic idiopathic constipation: a controlled clinical trial
    Timna Naftali
    Department of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba, Israel
    Digestion 78:224-8. 2008
    ..Constipated patients received liquid Z. jujuba or placebo for 12 weeks. Subjects completed questionnaires, a visual analog scale and transit time (TT) tests before and after treatment...
  5. ncbi request reprint Post-infectious gastroparesis: clinical and electerogastrographic aspects
    Timna Naftali
    Motility Clinic, Gastroenterology Division, Meir Hospital, Kefar Saba, Israel
    J Gastroenterol Hepatol 22:1423-8. 2007
    ..The aim of this study was to identify post-viral gastroparesis and to characterize clinical and electrogastrographic aspects of the disease and their usefulness as a diagnostic tool...
  6. ncbi request reprint Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation
    Timna Naftali
    Institute of Gastroenterology and Liver Diseases, Meir Hospital, Kfar Saba, Israel
    Isr Med Assoc J 9:504-8. 2007
    ..Interleukin-18 is a pro-inflammatory cytokine that is up-regulated in Crohn's disease. IL-18 binding protein neutralizes IL-18. The relationship of IL-18 and IL-18BP and disease activity in these diseases is not fully understood...
  7. ncbi request reprint [Intra gastric balloon for morbid obesity]
    Naftali Timna
    Sapir Medical Center, Meir Hospital, Kefar Saba
    Harefuah 145:826-30, 861. 2006
    ..Patients should be carefully selected and monitored to avoid complications...
  8. ncbi request reprint Cyclosporin for severe ulcerative colitis
    T Naftali
    Department of Gastroenterology, Meir Hospital, Kfar Saba
    Isr Med Assoc J 2:588-91. 2000
    ..About one-third of patients with severe ulcerative colitis do not respond to conventional therapy and require urgent colectomy. It was recently shown that cyclosporin is effective in some of these patients...
  9. pmc High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance
    R Towers
    Institute of Gastroenterology and Liver Diseases, Meir Hospital, Kfar Saba 4428, Israel
    Clin Exp Immunol 141:357-62. 2005
    ..IL-18 might participate in the alternative splicing of the hGR preliminary mRNA of CD patients. The results support the theory that augmented hGRbeta mRNA expression level in PBMC is connected with GC-resistance of CD patients...
  10. pmc Helicobacter pylori: the Middle East scenario
    B H Novis
    Gastroenterology Unit, Meir Hospital, Kfar Saba, Israel
    Yale J Biol Med 71:135-41. 1998
    ..The H. pylori scenario from the prevalence rates, treatment protocols and responses to treatment does not differ very much from other developing areas of the world...